Skip to main content
Log in

Ist die Teilbrustbestrahlung beim Mammakarzinom eine sinnvolle Innovation?

Value of partial breast radiation in treatment for mammary carcinoma

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Bartelink H et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387

    Article  PubMed  CAS  Google Scholar 

  2. Fisher B et al. (1995) Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456–1461

    Article  PubMed  CAS  Google Scholar 

  3. Fisher B et al. (2002) Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimetre or less. J Clin Oncol 20: 4141–4149

    Article  PubMed  CAS  Google Scholar 

  4. Fyles AW et al. (2004) Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351: 963–970

    Article  PubMed  CAS  Google Scholar 

  5. Giordano SH et al. (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97: 419–424

    Article  PubMed  Google Scholar 

  6. Morrow M et al. (1995) Local control following breast-conserving surgery for invasive cancer: results of clinical trials. J Natl Cancer Inst 87: 1669–1673

    Article  PubMed  CAS  Google Scholar 

  7. Sauer R et al. (2005) Teilbrustbestrahlung nach brusterhaltender Operation bei Brustkrebs. Strahlenther Onkol 181: 417–423

    Article  PubMed  Google Scholar 

  8. Winzer KJ et al. (2004) Radiation therapy after breast-conserving surgery: first results of a randomised clinical trial in patients with low risk of recurrence. Eur J Cancer 40: 998–1005

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Herbolsheimer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herbolsheimer, M. Ist die Teilbrustbestrahlung beim Mammakarzinom eine sinnvolle Innovation?. Onkologe 14, 630–632 (2008). https://doi.org/10.1007/s00761-008-1400-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-008-1400-7

Navigation